Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. If morals came in the form of a pill, would we use them?

If morals came in the form of a pill, would we use them?

Stories Feb 5, 2018 3 minutes

People are nervous about the thought of bioenhancements to curb bullying.

With sexual harassment and bullying dominating headlines, many people may be wondering what interventions the public would support to prevent immoral and harmful behaviours. Answering this question is the subject of a recent study led by Vancouver Coastal Health Research Institute researcher Peter Reiner. 

Reiner and colleagues designed an online survey that asked members of the public if they would, in one case, condone using a bioenhancement pill—one that would improve morality—to address the bullying behaviour of a child.

“There are few issues that are more contentious than moral bioenhancement.”  

The hypothetical scenario presented to respondents is about a 13-year-old child who is bullying another student at school. In this scenario, the concern was that the child’s bullying behaviour would escalate should he or she not undertake an empathy-enhancing video game program or take a natural hormone oxytocin pill on a daily basis for four weeks. Both programs were said to be equally effective and safe.  

“We wanted to make the issue as non-controversial as possible,” says Reiner. “Which is why we chose a behaviour that is generally condemned as morally reprehensible, but not illegal, and a pharmacological moral bioenhancement that was as innocuous as possible.”

Peter Reiner is a professor in the Department of Psychiatry at the University of British Columbia and co-founder of the National Core for Neuroethics.

Two hundred and ninety-three respondents received one of four surveys outlining different scenarios, involving either their hypothetical child as the bully or as being bullied. In one survey, respondents were asked if they would opt for their child to receive the pill intervention, in another, the bully to receive the pill intervention. Two other surveys put the video game program in place of the pill. All respondents were then asked to rate their support for such things as making the program mandatory and requiring participation of children at higher risk of becoming bullies, all children or even the entire population, including themselves. 

The results were resoundingly in favour of non-biomedical moral enhancement interventions in all cases. 

“We anticipated that the results would differ between the scenarios where someone’s child was either the subject or object of bullying,” says Reiner, “but it turns out that respondents felt strongly in equal measure against giving a child a pill.”

A possible reason for this, Reiner says, is that drugs were seen as a shortcut to achieving moral clarity, which is something that respondents may believe requires more time and work. 

Public beliefs an important consideration for policies to curb immoral behaviour 

Reiner decided to explore this area of research to address other papers that equate bioenhancements with non-biological interventions in terms of the effect they have on the human brain. 

Some arguments, Reiner notes, including those of Ingmar Persson and Julian Savulescu, have even raised the possibility of obligating the use of moral enhancements that have been deemed safe.

“This is a very contentious area of philosophy that borders on neuroscience.”

There is some evidence showing bioenhancements and psychological moral enhancement programs have similar biological and psychological effects and outcomes. However, Reiner believes the results of their study demonstrate that public support would likely be squarely behind non-pharmacological interventions. 

“We found that, even if there was a push to use moral bioenhancements more broadly in the population, at minimum, democratic societies would need to have the consent of the population first,” Reiner says. “And we concluded that the population hated the idea of using drugs for moral enhancement.” 

Their paper closes by suggesting that, from a public policy point of view, there would be little to no practicality of proposing the widespread use of moral bioenhancements. 
 

Researchers

Peter Reiner

Related Articles

Mental health pre- and post-recreational cannabis legalization

Timely wrap-around support for people with type 1 diabetes

Prioritizing mental health care with the Mood Disorders Centre

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Investigator Awards 2025 Recipients

Apr 29, 2025 award
Type
Stories

Ask an expert: What should I know about kidney stones?

Apr 23, 2025 kidney, treatment options
Type
Stories

New solution to treat obstructive sleep apnea

Apr 22, 2025 sleep, treatment options
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy